Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Carprofen
Norbrook Laboratories Limited
Anti-inf
Carprofen
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Anti Inflammatory NSAID
Expired
2006-01-30
Revised: November 2010 AN: 00399/2010 Page 1 of 5 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Norocarp 5.0% w/v Large Animal Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Carprofen 5.0% w/v EXCIPIENTS: Ethanol 10.0% v/v (as preservative) Sodium Formaldehyde Sulphoxylate 0.20% w/v (as antioxidant) For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Solution for Injection. A clear colourless to pale yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Young cattle (under 12 months of age) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In young cattle (under 12 months old) the product is indicated as adjunctive therapy for the control of acute inflammation associated with respiratory disease. The cause of the condition should be determined and treated with an appropriate antimicrobial. 4.3 CONTRAINDICATIONS Do not exceed the stated dose or the duration of treatment. Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Do not use in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product. Revised: November 2010 AN: 00399/2010 Page 2 of 5 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Do not use in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or hypersensitivity to the product. As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events. Use in animals less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided, animals may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased Read the complete document